Author: Lox C.D.
Publisher: Elsevier
ISSN: 0306-3623
Source: General Pharmacology, Vol.27, Iss.2, 1996-03, pp. : 367-370
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New developments in contraceptive drugs for use by women
By Glasier Anna
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. :
Delayed Developmental Effects Following Prenatal Exposure to Drugs
Current Pharmaceutical Design, Vol. 7, Iss. 9, 2001-06 ,pp. :
Blood Chemistry Profiles in Menopausal Women Administered Tamoxifen for Breast Cancer
By Lox C. Ronaghan C. Cobos E.
General Pharmacology, Vol. 30, Iss. 1, 1998-01 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. :